Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2017 by Cancer Insight, LLC
Genentech, Inc.
Galena Biopharma, Inc.
Information provided by (Responsible Party):
George E. Peoples, Cancer Insight, LLC Identifier:
First received: March 25, 2012
Last updated: April 5, 2017
Last verified: April 2017
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2020
  Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)